Table of Contents:

1 Report Prologue
2 Executive Summary
3 Market Introduction
3.1 Definition
3.2 Scope of the Study
3.3 Assumptions & Limitations
3.3.1 Assumptions
3.3.2 Limitations
3.4 Market Structure
4 Research Methodology
4.1 Research Process
4.2 Primary Research
4.3 Secondary Research
4.4 Market Size Estimation
4.5 Forecast Model
5 Market Dynamics
5.1 Introduction
5.2 Drivers
5.2.1 Increasing prevalence of respiratory diseases
5.2.2 Growth in the elderly population
5.2.3 Increasing prevalence of lung cancer
5.3 Restraints
5.3.1 Stringent regulatory policies
5.3.2 Rising cost of pulmonary devices
5.4 Opportunities
5.4.1 Increasing scope of high-potency pulmonary function testing devices
6 Market Factor Analysis
6.1 Value Chain Analysis
6.1.1 Raw Material
6.1.2 Supplier
6.1.3 Manufacturer
6.1.4 Distributor
6.1.5 Customer
6.1.6 Consumer
6.2 Porter's Five Forces Analysis
6.2.1 Threat of New Entrants
6.2.2 Bargaining Power of Suppliers
6.2.3 Bargaining Power of Buyers
6.2.4 Threat of Substitutes
6.2.5 Intensity of Rivalry
6.3 Investment Opportunities
6.4 Price Analysis
7 Global Pulmonary Function Testing Systems Market by Type
7.1 Overview
7.2 Complete PFT Systems
7.3 Portable PFT Systems
8 Global Pulmonary Function Testing Systems Market by Test Type
8.1 Overview
8.2 Spirometry
8.3 Lung Volume
8.4 Gas Exchange Testing
8.5 Maximal Voluntary Ventilation
8.6 Oxygen Titration Test
8.7 High Altitude Simulation Testing
9 Global Pulmonary Function Testing Systems Market by Component
9.1 Overview
9.2 Software
9.3 Hardware
9.4 Services
10 Global Pulmonary Function Testing Systems Market by Application
10.1 Overview
10.2 Chronic Obstructive Pulmonary Disease
10.3 Asthma
10.4 Chronic Shortness of Breath
10.5 Restrictive Lung Disease
11 Global Pulmonary Function Testing Systems Market by End-user
11.1 Overview
11.2 Hospital/Clinical Laboratories
11.3 Diagnostics Laboratories
12 Global Pulmonary Function Testing Systems Market by Region
12.1 Overview
12.2 Americas
12.2.1 North America
12.2.1.1 US
12.2.1.2 Canada
12.2.2 South America
12.3 Europe
12.3.1 Western Europe
12.3.1.1 Germany
12.3.1.2 France
12.3.1.3 UK
12.3.1.4 Italy
12.3.1.5 Spain
12.3.1.6 Rest of Western Europe
12.3.2 Eastern Europe
12.4 Asia-Pacific
12.4.1 Japan
12.4.2 China
12.4.3 India
12.4.4 Australia
12.4.5 South Korea
12.4.6 Rest of Asia-Pacific
12.5 Middle East & Africa
12.5.1 Middle East
12.5.2 Africa
13 Competitive Landscape
13.1 Company Market Share Analysis
13.1.1 Introduction
13.2 Competitive Scenario
13.2.1 Introduction
14 Company Profiles
14.1 COSMED srl
14.1.1 Company Overview
14.1.2 Financial Overview
14.1.3 Products/Services Offering
14.1.4 Key Developments
14.1.5 SWOT Analysis
14.1.6 Key Strategy
14.2 Vyaire Medical, Inc
14.2.1 Company Overview
14.2.2 Financial Overview
14.2.3 Products/Services Offering
14.2.4 Key Developments
14.2.5 SWOT Analysis
14.2.6 Key Strategy
14.3 Schiller
14.3.1 Company Overview
14.3.2 Financial Overview
14.3.3 Products/Services Offering
14.3.4 Key Developments
14.3.5 SWOT Analysis
14.3.6 Key Strategy
14.4 Medical Equipment Europe GmbH
14.4.1 Company Overview
14.4.2 Financial Overview
14.4.3 Products/Services Offering
14.4.4 Key Developments
14.4.5 SWOT Analysis
14.4.6 Key Strategy
14.5 Medical Electronic Construction
14.5.1 Company Overview
14.5.2 Financial Overview
14.5.3 Products/Services Offering
14.5.4 Key Developments
14.5.5 SWOT Analysis
14.5.6 Key Strategy
14.6 ECO MEDICS AG
14.6.1 Company Overview
14.6.2 Financial Overview
14.6.3 Products/Services Offering
14.6.4 Key Developments
14.6.5 SWOT Analysis
14.6.6 Key Strategy
14.7 CHEST M.I., Inc
14.7.1 Company Overview
14.7.2 Financial Overview
14.7.3 Products/Services Offering
14.7.4 Key Developments
14.7.5 SWOT Analysis
14.7.6 Key Strategy
14.8 MGC Diagnostic Corporation
14.8.1 Company Overview
14.8.2 Financial Overview
14.8.3 Products/Services Offering
14.8.4 Key Developments
14.8.5 SWOT Analysis
14.8.6 Key Strategy
14.9 ndd Medical Technologies
14.9.1 Company Overview
14.9.2 Financial Overview
14.9.3 Products/Services Offering
14.9.4 Key Developments
14.9.5 SWOT Analysis
14.9.6 Key Strategy
15 Appendix
15.1 Discussion Blue Print